RoActemra tocilizumab regulatory update

Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: RoActemra tocilizumab ( RG1569) Business: Autoimmune The U.K.'s NICE issued a third preliminary appraisal for RoActemra tocilizumab from Roch...